We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Revvity AlphaLISA SureFire Ultra Mouse Total RIP3
List Price
$53,693.50
Your Price
$53,693.50
Revvity AlphaLISA SureFire Ultra Mouse Total RIP3 Detection Kit, 50,000 Assay Points - REV
NETA PART:
REV-ALSU-TRIP3-B50K
MFG.PART:
ALSU-TRIP3-B50K
UNSPSC:
41105332
Manufacturer:
Revvity
Receptor-interacting serine/threonine-protein kinase 3 (RIPK3) is a critical regulator of programmed necroptosis, an inflammatory form of cell death with important functions in pathogen-induced and sterile inflammation. RIP3 mediates necroptosis in conjunction with RIPK1 and MLKL. Due to the inflammation caused by necroptosis, RIPK3 is associated with a variety of inflammatory diseases.
The AlphaLISA SureFire Ultra Mouse Total RIP3 assay is a sandwich immunoassay for the quantitative detection of total RIP3 in cellular lysates, using Alpha Technology.
Formats:
- The HV (high volume) kit contains reagents to run 100 wells in 96-well format, using a 60 μL reaction volume.
- The 500-point kit contains enough reagents to run 500 wells in 384-well format, using a 20 μL reaction volume.
- The 10,000-point kit contains enough reagents to run 10,000 wells in 384-well format, using a 20 μL reaction volume.
- The 50,000-point kit contains enough reagents to run 50,000 wells in 384-well format, using a 20 μL reaction volume.
AlphaLISA SureFire Ultra kits are compatible with:
- Cell and tissue lysates
- Antibody modulators
- Biotherapeutic antibodies
Alpha SureFire kits can be used for:
- Cellular kinase assays
- Receptor activation studies
- Screening
| SKU | REV-ALSU-TRIP3-B50K |
|---|---|
| Supplier Part Number | ALSU-TRIP3-B50K |
| UM | EA |
| UNSPSC | 41105332 |
| Manufacturer | Revvity |
| CountryOfOrigin | Australia |
| ProductLine | REV |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 5 |
| Hazardous | N |
| Energy Star | No |
| Green | No |
| Controlled | N |